Clinical Trials Directory

Trials / Conditions / Cerebral Adrenoleukodystrophy (CALD)

Cerebral Adrenoleukodystrophy (CALD)

6 registered clinical trials studyying Cerebral Adrenoleukodystrophy (CALD) — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel
NCT06224413
Genetix Biotherapeutics Inc.—
RecruitingA Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adren
NCT05819866
Minoryx Therapeutics, S.L.Phase 3
CompletedA Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukody
NCT03852498
Genetix Biotherapeutics Inc.Phase 3
Active Not RecruitingLong-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Prod
NCT02698579
Genetix Biotherapeutics Inc.—
TerminatedObservational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)
NCT02204904
Genetix Biotherapeutics Inc.—
CompletedA Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for t
NCT01896102
Genetix Biotherapeutics Inc.Phase 2 / Phase 3